Long non-coding RNAs: Tools for understanding and targeting cancer pathways
Simple Summary Long non-coding RNA (lncRNA) is a type of RNA molecule that show
striking resemblance to mRNA in terms of synthesis and structure but lacks protein coding …
striking resemblance to mRNA in terms of synthesis and structure but lacks protein coding …
Long non-coding RNAs, extracellular vesicles and inflammation in Alzheimer's disease
A Canseco-Rodriguez, V Masola, V Aliperti… - International Journal of …, 2022 - mdpi.com
Alzheimer's Disease (AD) has currently no effective treatment; however, preventive
measures have the potential to reduce AD risk. Thus, accurate and early prediction of risk is …
measures have the potential to reduce AD risk. Thus, accurate and early prediction of risk is …
The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things
Y Fang, XL Zhang, HF Huang, Z Zeng - Journal of Translational Medicine, 2023 - Springer
Hepatocellular carcinoma (HCC) is the leading cause of cancer-related death in people, and
a common primary liver cancer. Lacking early diagnosis and a high recurrence rate after …
a common primary liver cancer. Lacking early diagnosis and a high recurrence rate after …
Long non-coding RNAs in cancer: multifaceted roles and potential targets for immunotherapy
Cancer remains a major global health concern with high mortality rates mainly due to late
diagnosis and poor prognosis. Long non-coding RNAs (lncRNAs) are emerging as key …
diagnosis and poor prognosis. Long non-coding RNAs (lncRNAs) are emerging as key …
LncRNA/miRNA/mRNA network introduces novel biomarkers in prostate cancer
The construction of a competing endogenous RNA (ceRNA) network is an important step in
the identification of the role of differentially expressed genes in cancers. In the current …
the identification of the role of differentially expressed genes in cancers. In the current …
LncRNA weighted gene co-expression network analysis reveals novel biomarkers related to prostate cancer metastasis
M Liu, MY Chen, JM Huang, Q Liu, L Wang, R Liu… - BMC medical …, 2022 - Springer
Background Most prostate cancer patients die from metastasis and lack accurate efficacious
biomarkers to monitor the disease behavior, optimize treatment and assess prognosis …
biomarkers to monitor the disease behavior, optimize treatment and assess prognosis …
Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer
Long non-coding RNAs (lncRNAs) are regulatory transcripts with essential roles in the
pathogenesis of almost all types of cancers, including prostate cancer. They can act as …
pathogenesis of almost all types of cancers, including prostate cancer. They can act as …
[HTML][HTML] Predicting prostate cancer progression with a Multi-lncRNA expression-based risk score and nomogram integrating ISUP grading
S Ledesma-Bazan, F Cascardo, J Bizzotto… - Non-coding RNA …, 2024 - Elsevier
Prostate cancer is a highly heterogeneous disease; therefore, estimating patient prognosis
accurately is challenging due to the lack of biomarkers with sufficient specificity and …
accurately is challenging due to the lack of biomarkers with sufficient specificity and …
[HTML][HTML] Transcript Markers from Urinary Extracellular Vesicles for Predicting Risk Reclassification of Prostate Cancer Patients on Active Surveillance
K Erdmann, F Distler, S Gräfe, J Kwe, HHH Erb… - Cancers, 2024 - mdpi.com
Simple Summary Active surveillance is the preferred treatment strategy for low-risk prostate
cancer and includes regular monitoring by control biopsies, which bear the risk of various …
cancer and includes regular monitoring by control biopsies, which bear the risk of various …
Novel PRUNE2 Germline Mutations in Aggressive and Benign Parathyroid Neoplasms
S Storvall, E Ryhänen, A Karhu, C Schalin-Jäntti - Cancers, 2023 - mdpi.com
Simple Summary Recently, PRUNE2 mutations were indicated in the pathogenesis of
aggressive parathyroid neoplasms. Here, we report novel, rare PRUNE2 mutations located …
aggressive parathyroid neoplasms. Here, we report novel, rare PRUNE2 mutations located …